Diseases in Medical Technology

Tiny Cup Attached to Eye Improves Drug Delivery For Retinal Diseases

... change how we deliver medications to the eye for diseases like macular degeneration, diabetic retinopathy, ... vision. Currently, drugs for most retinal diseases are delivered either through an I.V. drip (i.e. ... drops are also generally ineffective for retinal diseases because most medications are washed away or ...

Neuroscience Researcher Has Positive Message for International Alzheimer's Awareness Week, July 6 - 12: 'Even Though World Economy is Declining, Alzheimer's Research is Advancing'

... for Alzheimer's disease and other degenerative diseases of the brain that cause memory loss may be much ... to treat age related memory loss and the diseases of aging. The company's therapeutic products ... ions thought to be related to neurodegenerative diseases such as Alzheimer's and Parkinson's. Web: ...

ALP Life Sciences, LLC Announces Nanoveson(TM) Patent Filing and Whitepaper Availability on Proposed Therapy for Non-Alcoholic Fatty Liver Disease (NAFLD) and Comorbid Diseases

... NAFLD is known to progress to more advanced liver diseases such as non-alcoholic steatohepatitis (NASH), ... a novel approach to treating and diagnosing liver diseases and comorbid diseases utilizing the principles of Applied Lipid ...

CeNeRx BioPharma Obtains Rights to Novel Drug Candidate for Prevention and Treatment of Neurodegeneration Disorders

... and commercializing innovative treatments for diseases of the central nervous system (CNS), today ... for devastating neuropathic and neurodegenerative diseases that lack effective therapies. We intend to move ... and commercializing innovative treatments for diseases of the central nervous system. CeNeRx's most ...

New Legislation Seeks to Boost Participation in Clinical Trials for Rare Diseases

... introduced today would allow patients with rare diseases to participate in clinical drug studies without ... prevents significant numbers of people with rare diseases from participating in clinical studies. Researchers developing drugs to treat rare diseases struggle to recruit participants for clinical ...

Isis Highlights New Data on Antisense Drugs to Treat Type 2 Diabetes and Obesity at ADA Scientific Sessions

... and broaden our drug pipeline to address new diseases within our core therapeutic programs in cardiovascular, metabolic and severe neurodegenerative diseases and cancer." Including presentations ... metabolic and severe neurodegenerative diseases and cancer. Isis' partners are developing ...

PROTECT-1 Phase II/III Induction-Stage Results for ChemoCentryx's Traficet-EN(TM) Presented in Oral Session at DDW 2009 Conference

... "No cure exists for inflammatory bowel diseases and many patients do not respond to or cannot ... and intended for subsequent development to treat diseases such as Type 2 diabetes, multiple sclerosis and ... clinical trial, being developed for inflammatory diseases such as rheumatoid arthritis. ChemoCentryx also ...

Trubion Announces Positive Data From a Phase 1 / 2 Study of TRU-016 for the Treatment of Chronic Lymphocytic Leukemia (CLL)

... used in combination with other therapies. These diseases are not curable presently, and eventually patients with these diseases show diminished response to current therapies. ... candidates to treat autoimmune and inflammatory diseases and cancer. The Company's mission is to develop a ...

Scientific Data Relating to Cinryze(TM) Presented at 6th Annual C1 Inhibitor Deficiency Workshop

... meeting the needs of patients with C1 deficiency diseases today, and tomorrow," commented Glenn Tillotson, ... of products that address serious diseases treated by physician specialists and in hospital ... focuses its drug development activities in diseases including cytomegalovirus (CMV), HAE and C. ...

One Step Closer: Novel Opioid Receptor Compound in Phase I Clinical Trials

... for treating reward disorders and a number of diseases because of its long-lasting effect in animal ... for the treatment of a broad range of diseases and medical conditions, including addiction, ... to identify novel therapies to treat human diseases and find possible solutions that work. Most ...

Paloma Pharmaceuticals Presents at the Association for Research in Vision and Ophthalmology 2009 Meeting

... represents a novel therapy for other retinal diseases such as proliferative vitreoretinopathy, macular ... data showing the versatility of Palomid 529 for diseases of retinal and subretinal origin. Furthermore, ... can occur following trauma or as part of certain diseases of the eye resulting in blindness in the affected ...

Optherion Announces Issuance of Canadian Patents Covering Age-Related Macular Degeneration Diagnostics and Treatments

... Macular Degeneration (AMD) and other chronic diseases involving the alternative complement system, ... treating patients with AMD and other diseases of the alternative complement system. As we ... Macular Degeneration (AMD) and other chronic diseases involving the alternative complement system. ...

Progress Against Malaria and Other Infectious Diseases Among Highlights at Annual Vaccine Conference

... by the National Foundation for Infectious diseases (NFID) April 27-29, 2009 in Baltimore. The ACVR ... we are making against such fatal and debilitating diseases as Group A meningitis in Africa. These advances ... like autism. Now, alarmingly, vaccine preventable diseases are starting to come back." The Merieux ...

Intercell Starts a Phase I Clinical Trial for a New Streptococcus pneumoniae Vaccine

... in the development of vaccines against infectious diseases with significant unmet medical need," commented ... for the prevention and treatment of infectious diseases with substantial unmet medical needs. Intercell's ... three other products focused on infectious diseases are in pre-clinical development. Intercell ...

Transgenomic and Power3 Medical Complete Agreement for Exclusive License of Neurodegenerative Biomarker Test

... Early Detection of Alzheimer's and Parkinson's diseases OMAHA, Neb. and HOUSTON, Feb. 2 ... diagnostic for Alzheimer's and Parkinson's diseases based on Power3's proteomics platform. ... as Alzheimer's, Parkinson's or Lou Gehrig's (ALS) diseases from "normal" individuals and patients with other ...

Study Shows How Defective DNA Repair Triggers Two Neurological Diseases

... and cancer vulnerability in people carrying the diseases MEMPHIS, Tenn., Jan. 14 ... involved the use of mouse models of each the diseases to analyze how the gene defects in ATLD and NBS ... to ATLD, highlighting the connections between diseases resulting from defects in this DNA repair ...

Intra-Cellular Therapies Announces Successful Outcome of a Phase II Clinical Trial with ITI-007 in Patients with Sleep Maintenance Insomnia

... impairment and schizophrenia) and neurological diseases (e.g. Parkinson's and Alzheimer's diseases). ... developing novel drugs for the treatment of diseases and disorders of the Central Nervous System ... that have the potential to treat a wide range of diseases associated with the CNS, including schizophrenia, ...

Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program

... biopharmaceutical company focused on diseases of epidemic potential, announced today that ... the National Institute of Allergy and Infectious diseases (NIAID), National Institutes of Health (NIH), is ... emerging and re-emerging infectious tropical diseases and bioweapon pathogens. The Phase 1B clinical ...

Two New Studies in the New England Journal of Medicine Show Malaria Vaccine Candidate Advancing in Africa

... of Research & Development, Emerging diseases & HIV at GSK Biologicals. "The energy ... centre tackling malaria and other important diseases in Kenya. Safeguarding the health of young ... which protect the world's children from up to six diseases in one vaccine. About the PATH Malaria ...

Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome

... (iii) Sakoulas, G et al. Clinical Infectious diseases 2006; 42: S40-S50. (iv) Tenover F, Moellering RC Jr. Clinical Infectious diseases 2007; 44: 1208-15. (v) Centers for ... (vi) Kuehnert MJ et al. Emerging Infectious diseases 2005; 11: 868-72. (vii) Klevens, RM et ....

42 Top U.S. Scientists and Specialists Explore Cutting-Edge Innovations to Defend America From Dangerous Zoonotic Diseases

... detects highly contagious and dangerous zoonotic diseases in people before symptoms appear. ... Security Center of Excellence. Zoonotic diseases attack both humans and animals. The most dangerous of these diseases pose catastrophic risks to U.S. public health and ...

Parasites That Live Inside Cells Use Loophole to Thwart Immune System

... member of the St. Jude departments of Infectious diseases and Immunology. Previously other researchers ... said. Such drugs might suppress such diseases as tuberculosis and toxoplasmosis by increasing ... for tuberculosis and parasites--dealing the diseases a therapeutic one-two punch. Other authors of ...

Durezol(TM) in the Treatment of Uveitis and Ganciclovir in the Treatment of Herpetic Keratitis: Studies of Treatments for Leading Causes of Blindness to Be Presented

... for treatment of potentially blinding eye diseases will be presented at upcoming ophthalmology ... Durezol is contraindicated in patients with viral diseases of the cornea and conjunctiva, and those with ... portfolio includes products that address ocular diseases and conditions including uveitis, herpetic ...

Pivotal Phase III Data Confirm the Efficacy and Safety of Arpida's Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections

... Agents and Chemotherapy (ICAAC)/Infectious diseases Society of America (IDSA) 46th annual meeting in ... v Sakoulas, G et al. Clinical Infectious diseases 2006; 42: S40-S50. vi Tenover F, Moellering RC Jr. Clinical Infectious diseases 2007; 44: 1208-15. vii Centers for ...

Data Reported at ICAAC Indicates Selzentry(TM) Phase III Treatment-Naive Trial Shows Increased Efficacy When Used With Enhanced Trofile(TM) Assay

... (ICAAC) / 46th Annual Meeting of the Infectious diseases Society of America (IDSA) in Washington DC. ... David Hardy, MD, Director, Division of Infectious diseases at Cedars-Sinai Medical Center and Associate ... Dr. Hardy is Director, Division of Infectious diseases at Cedars-Sinai Medical Center and is ...

Sirion Therapeutics Announces Positive Pivotal Uveitis Data for Durezol(TM)

... dosed four times a day in ocular inflammatory diseases had been demonstrated in an extensive preclinical ... Durezol is contraindicated in patients with viral diseases of the cornea and conjunctiva, and those with ... portfolio includes products that address ocular diseases and conditions including uveitis, herpetic ...

Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain

... safety of difluprednate in ocular inflammatory diseases had been demonstrated in an extensive preclinical ... is contraindicated in patients with viral diseases of the cornea and conjunctiva, and also in ... portfolio includes products that address ocular diseases and conditions including uveitis, herpetic ...

Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis

... as infectious, parasitic, malignant or autoimmune diseases and allergies, are potential therapeutic or ... have shown protection against a number of diseases in animal tests and are being tested against diseases associated with bio-defense and avian flu. When ...

Isis Initiates Clinical Trial of CRP Drug

... frequently elevated in patients with a variety of diseases including cardiovascular disease, Crohn's ... CRP has been used as a clinical biomarker of diseases with an inflammatory component, such as ... CRP's active participation in these diseases remains to be determined, several lines of ...

New Research Shows One in 200 People Born with DNA Mutation That Can Lead to Devastating, Often Fatal Disease

... disorders are at the core of many well known diseases and chronic illnesses, such as Alzheimer's ... is connected to other diseases." Mitochondrial diseases are extremely complicated and often ... the risk for developing a wide variety of diseases including diabetes, cardiovascular disease, ...

Cytopia Appoints Study Chairman for JAK2 Clinical Trial

... myelofibrosis. Many of these particular diseases can lead to life threatening conditions such as ... attention on developing a therapy for these diseases through selective inhibition of JAK2. To successfully address these chronic diseases with a JAK2 inhibitor, the specificity ...

New Research Provides Evidence that Tea May Improve Attention and Focus, Keep Brain Cells Healthy, & Influence Genetics in Cancer

... of the Eve Topf Center for Neurodegenerative diseases in Israel, show that the active flavonoids in tea ... a decade, looked at animal models of neurological diseases such as Parkinson's and Alzheimer's. An amount of ... or how gene susceptibility toward chronic diseases can be altered through dietary interventions. ...

Study Shows Use of AdvanDx's PNA FISH(TM) Test was Associated with an 82% Reduction in Intensive Care Unit Mortality Rates from Staphylococcus aureus Bloodstream Infections

... by clinicians in the Section of Infectious diseases at Washington Hospital Center (WHC) in ... author Shmuel Shoham, M.D., Section of Infectious diseases and Director of Transplant Infectious diseases at Washington Hospital Center. "There was also a ...

Edison Pharma Hits Milestone as A0001 Enters Phase 1 Clinical Development

... Targeting inherited mitochondrial diseases as an archetype for diseases of aging SAN ... CoQ10 is a first-line therapy for many rare diseases of energy metabolism. Efforts to improve CoQ10 ...

Vical Advances RapidResponse(TM) DNA Vaccine Platform Under $6 Million Grant from NIH

... manufacture and deploy vaccines against emerging diseases during the early stages of an ... of manufacturing conventional vaccines for diseases such as influenza, which use viruses grown in ... against pandemic influenza and other infectious diseases at Vical, are manufactured by bacterial ...

AlphaVax Continues to Expand the Use of Its Vaccine Platform

... National Institute of Allergies and Infectious diseases (NIAID), one of the granting institutes of the ... vector platform to address many different diseases as well as bioterrorism threats. We have ... the National Institute of Allergy And Infectious diseases or the National Institutes of Health. ...

ChemoCentryx Initiates Clinical Trial of CCR1 Inhibitor CCX354

... the inflammation underlying certain autoimmune diseases such as rheumatoid arthritis (RA), as well as ... against a number of potential inflammatory diseases and we look forward to seeing the data as it ... in Phase I and may subsequently be developed for diseases such as vascular restenosis, Type 2 diabetes ...

St. Jude Study Shows How T Cell's Machinery Dials Down Autoimmunity

... own organs, tissues or cells. Some 80 autoimmune diseases are known, including type 1 diabetes, ... "Among the many mysteries surrounding autoimmune diseases is why they can sometimes take decades to ... might provide insight into how autoimmune diseases start. "One implication of our findings is ...

Neurocrine Biosciences Reports First Quarter 2008 Results

... in treating other hormone-dependent diseases in Men's and Women's Health. Corticotropin ... company focused on neurological and endocrine diseases and disorders. Our product candidates address ... and other neurological and endocrine related diseases and disorders. Indiplon was licensed from ...

Rigel's R788 Slows Progression of Murine Lupus in Preclinical Studies

... complications. Like other autoimmune diseases the primary characteristic of lupus is ... for the treatment of inflammatory/autoimmune diseases and cancer, as well as viral and ... development programs in inflammatory/autoimmune diseases such as rheumatoid arthritis, thrombocytopenia ...